GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDING CO., LTD. Funds and ETFs Guangzhou Baiyunshan Pharmaceutical Holding Co., Ltd.
Equities
874
CNE100000387
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.05 HKD | +0.22% |
|
+6.47% | +5.98% |
| 04-26 | Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 03-18 | Baiyunshan Pharmaceutical's 2023 Profit Rises 2% | MT |
ETFs positioned on Guangzhou Baiyunshan Pharmaceutical Holding Co., Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.09% | 4 M€ | -27.92% | ||
| 0.00% | 32 M€ | +8.03% | - | |
| 0.00% | 34 M€ | +3.53% | - |
Guangzhou Baiyunshan Pharmaceutical Holding Co., Ltd. specializes in researching, developing and manufacturing pharmaceutical products. The group's products include analgesics, antibiotics, medicines for the treatment of stomach disorders, treatment of cough, antitoxic products, etc.
Sector
Pharmaceuticals
Calendar
30/05/2024
- Shareholders Meeting
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
21.34
CNY
Average target price
22.1
CNY
Spread / Average Target
+3.55%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +5.98% | 7.08B | |
| +31.37% | 588B | |
| -3.34% | 364B | |
| +19.13% | 326B | |
| +5.19% | 285B | |
| +15.13% | 239B | |
| +10.06% | 210B | |
| -7.03% | 200B | |
| +9.74% | 167B | |
| -0.51% | 161B |
- Stock Market
- Equities
- 874 Stock
- Funds and ETFs Guangzhou Baiyunshan Pharmaceutical Holding Co., Ltd.
